FDA recall D-0862-2017

Hospira Inc. · Class I · drug

Product

Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1775-10

Reason for recall

Presence of Particulate Matter: human hair found within an internal sample syringe.

Distribution

Nationwide in the USA and Puerto Rico

Key facts

Status: Ongoing
Initiation date: 2017-04-21
Report date: 2017-05-31
Voluntary/Mandated: Voluntary: Firm initiated
Location: Lake Forest, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0862-2017